Clinical Trial Update: Betaferon/ Betaseron (Interferon Beta-1b) in Patients With Chronic Viral Cardiomyopathy [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating Interferon beta-1b (Betaferon/Betaseron) for chronic viral cardiomyopathy; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiomyopathy

Drugs mentioned

• Betaferon/ Betaseron (Interferon Beta-1b) (Interferon beta-1b)

Snippet

Sponsor: Bayer | Conditions: Cardiomyopathies, Heart Diseases | Phase 2 | Status: COMPLETED